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PURPOSE. Norrin is essential for the formation of the retinal vasculature during development
and promotes its repair after damage via activation of Wnt/b-catenin signaling. Since retinal
TGF-b signaling has essentially opposite effects on the retinal vasculature we investigated if
and how Norrin inhibits TGF-b signaling, and vice versa.
METHODS. Eyes from transgenic mice with an overexpression of Norrin (bB1-Norrin) and/or
active TGF-b (bB1-TGF-b1) in the lens were generated and analyzed by light microscopy,
immunohistochemistry, and TUNEL. Further on, protein as well as mRNA levels were
investigated by Western blot analyses and real-time RT-PCR, respectively.
RESULTS. In bB1-TGF-b1 mice, the lack of retinal vascular development and choriocapillaris
maintenance was rescued when transgenic Norrin was additionally overexpressed in the eye.
In addition, retinal Wnt/b-catenin signaling and the levels of SMAD7, an inhibitor of the
canonical TGF-b pathway, were substantially suppressed in retinae of bB1-TGF-b1 mice. In
contrast, Norrin normalized Wnt/b-catenin signaling and SMAD7 levels in double transgenic
mice. Moreover, in retinae of bB1-TGF-b1 mice, the amounts of phosphorylated SMAD3, a
downstream mediator of TGF-b signaling, were increased compared to those of bB1-Norrin/
bB1-TGF-b1 mice. In vitro, Norrin substantially reduced the TGF-b–mediated induction of
target genes, an effect that was blocked by Dickkopf-1, a specific inhibitor of Wnt/b-catenin
signaling.
CONCLUSIONS. High amounts of TGF-b in the eye cause a substantial reduction in the activity of
Wnt/b-catenin signaling. This effect is inhibited in the presence of high amounts of Norrin,
which further induce the expression of SMAD7 to inhibit TGF-b signaling.
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Norrin is a highly conserved secreted signaling moleculethat forms unique dimers with each monomer adopting a
conserved cystine knot fold.1,2 It is an atypical Wnt ligand that
binds to frizzled (FZD)4 and leucine-rich repeat-containing G-
protein–coupled receptors 4 to activate, in the presence of
their co-receptors low-density lipoprotein receptor-related
protein (LRP) 5 or 6, the canonical Wnt/b-catenin signaling
pathway.3,4 The intensity of Norrin-mediated FZD4 signaling is
enhanced in the presence of TSPAN12, which is supposed to
induce clustering of the FZD4/LRP5/6 receptor complexes.5
Norrin is essential for the formation of the normal retinal
vasculature and its lack in Norrin-deficient mice leads to
delayed formation of the superficial retinal vascular plexus on
the retinal surface, and to a complete lack of intraretinal
capillaries.6–9 The ocular phenotype of Norrin-deficient mice is
completely rescued by the additional transgenic overexpression
of Norrin in the eye.8 Besides their retinal phenotype, Norrin-
deficient mice suffer from an impaired vascularization of the
inner ear and cerebellum, strongly indicating a more general
role of Norrin for vessel formation in the central nervous
system.10–13 The vascular effects of Norrin are not restricted to
retinal angiogenesis during development, but also appear to be
important for vascular repair and maintenance. During oxygen-
induced retinopathy, the mouse model for retinopathy of
prematurity, Norrin promotes repair as it induces vessel
regrowth into vaso-obliterated areas and the formation of
intraretinal capillaries.7,14 As potential downstream mediators
of Norrin/b-catenin signaling in microvascular endothelial cells
during development and repair, the transcription factor SOX17
and the signaling molecule insulin-like growth factor-1 were
identified.15,16 Mutations in the encoding Norrie disease
protein (NDP) gene cause Norrie disease or familial exudative
vitreoretinopathy, conditions that are characterized by retinal
hypovascularization. In addition to its role in angiogenesis,
Norrin has distinct neuroprotective properties as it saves retinal
ganglion cells (RGC) or photoreceptors from apoptosis
following excitotoxic or light-induced damage.17–19 Norrin-
deficient mice are suffering from a continuous loss of retinal
ganglion cells that is rescued upon transgenic Norrin overex-
pression.6,8
Overall, the effects of Norrin on the retinal vasculature
during development and repair after injury are directly
opposite to those of TGF-b1 and 2, which are highly expressed
in the adult and developing retina.20,21 Mice with an induced
deletion of the TGF-b type II receptor, which is essential for
TGF-b signaling, show a pronounced neovessel formation of
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retinal capillaries including the formation of microaneurysms
and the phenotype of proliferative diabetic retinopathy.22 In
contrast, transgenic mice with TGF-b1 overexpression in the
eye do not develop intraretinal vessels and lose their
choriocapillaris, the capillary bed beneath the retinal pigment
epithelium that is essential for photoreceptor nutrition.23,24
The effects appear to be mediated via canonical TGF-b1
signaling, which involves the cytoplasmic phosphorylation of
SMAD2 and 3, which in turn bind to SMAD4.25,26 The
complexes then translocate into the nucleus to activate
specific target genes. Another SMAD molecule, SMAD7,
inhibits TGF-b signaling and appears to have an essential role
in an autoinhibitory negative feedback regulation of TGF-b
signaling.27,28 In humans, an enhanced expression of TGF-b is
associated with various ocular pathologies. In the posterior eye
segment, elevated levels of TGF-b were detected in the vitreous
humor of patients suffering from retinopathy of prematurity or
wet age-related macular degeneration, both conditions associ-
ated with retinal hypoxia.29,30 In contrast, in patients suffering
from proliferative diabetic retinopathy, TGF-b levels are
decreased.31 Overall, both experimental and clinical observa-
tions suggest a pivotal antiangiogenic role for TGF-b signaling
in the retina.
Because of the quite distinct and essentially opposing
effects of Norrin and TGF-b signaling on the proliferation of
ocular capillaries, we were interested to learn if the effects
might be mediated by a mutual interaction of their respective
signaling pathways. We provide evidence that high amounts of
TGF-b1 in the eye cause a dramatic reduction in the activity of
canonical Wnt/b-catenin signaling. This effect is inhibited in
the presence of high amounts of Norrin, which further induce
the expression of SMAD7 to inhibit the activity of TGF-b
signaling.
METHODS
Animals
All animal procedures performed in this study complied with
the ARVO Statement for the Use of Animals in Ophthalmic and
Vision Research, and were approved by the local authorities
(Regierung der Oberpfalz, Bavaria, Germany). The generation
of transgenic mice with an overexpression of Norrin (bB1-
Norrin) or activated TGF-b1 (bB1-TGF-b1) under the control of
the lens-specific chicken bB1-crystallin promoter fragment was
described previously in detail.8,32 Mice were bred in the animal
facility of the University of Regensburg. For PCR genotyping of
transgenic bB1-Norrin mice, primers that span from the
sequences of the bB1-crystallin promoter to those of the
Norrin cDNA were used. The sequences of the primers were
50-ACACTGATGAGGTGGCACTTCCATT-30 and 50-TGCATTCCT
CACAGTGACAGGAG-30. A 768 base pair (bp) DNA fragment
was amplified using the thermo cycle profile of denaturation at
948C for 30 seconds, annealing at 588C for 30 seconds and
extension at 728C for 1 minute for 30 cycles. To screen for
potential bB1-TGF-b1 mice, primers were used that span from
the bB1-chicken promoter to the SV40 intron of the transgene.
The sequences of the primers were 50-ACACTGATGAGCTGG
CACTTCCATT-30 and 50-TGTTGGCTACTTGTCTCACCATTGTA-
3 0. The primers were purchased from Life Technologies
(Carlsbad, CA, USA). A 506 bp DNA fragment was obtained
using the thermal cycle profile of denaturation at 948C for 30
seconds, annealing at 558C for 30 seconds, and extension at
728C for 45 seconds for 30 cycles. For all analyses transgenic
mice and wild type littermates of either sex were used.
To analyze retinal vasculature, mice were deeply anesthe-
tized with ketamine (120 mg/kg body weight, intramuscularly
[IM]) and xylazine (8 mg/kg body weight IM) at the indicated
time points, and then perfused through the left ventricle with 1
mL PBS containing 50 mg high molecular weight (MW ¼
2,000,000) FITC-dextran (TdB Consultancy, Uppsala, Sweden).
The eyes were enucleated and placed in 4% paraformaldehyde
(PFA; Carl Roth, Karlsruhe, Germany) for 4 hours. After
washing in PBS overnight, eyes were embedded in Tissue
Tek (Sakura Finetek, Torrance, CA, USA) according to standard
protocols and subjected to cryosectioning.
Expression and Purification of Human
Recombinant Norrin
The protocol for generation of the expression vector, and
synthesis and purification of human recombinant (hr) Norrin
has been reported in detail previously.7 Briefly, for expression
of hr Norrin, further referred to as Norrin, stably transfected
293 EBNA cells were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) containing 5% fetal calf serum (FCS), 20 lg/
mL gentamycin, 250 lg/mL geneticin (G418), and 300 lg/mL
hygromycin (all from Life Technologies). To harvest Norrin-
conditioned cell culture medium, cells were cultured in
medium without FCS for 3 days. Protein purification of
recombinant Norrin was performed by affinity chromatogra-
phy using heparin agarose (Sigma-Aldrich Corp., St. Louis, MO,
USA). After washing and equilibration in PBS, heparin agarose
(Sigma-Aldrich Corp.) was incubated with conditioned cell
culture medium for 1 hour at 48C and loaded on a fresh
chromatography column (Bio-Rad Laboratories, Hercules, CA,
USA). After washing three times with PBS, bound proteins
were eluted from agarose using 1 to 2 M NaCl in PBS. Eluted
fractions were analyzed by Western blot analyses using
antibodies against human Norrin (R&D Systems, Minneapolis,
MN, USA) and the HisTag epitope (Life Technologies). The
purity of Norrin-containing fractions was examined by silver
staining of an SDS polyacrylamide gel. After dialyzing against
PBS, protein content was measured by semiquantitative SDS
polyacrylamide gel and visualized by silver staining according
to standard protocol.
Cell Culture
Human retinal microvascular endothelial cells (HRMEC; Cell
Systems, Kirkland, WA, USA) were cultured in supplemented
microvascular endothelial cell growth medium (PromoCell,
Heidelberg, Germany) containing 100 U/mL penicillin (Life
Technologies) and 100 lg/mL streptomycin (Life Technologies)
at 378C and 5% CO2. Transfected mink lung epithelial cells
(MLECs) were cultured in DMEM supplemented with 10% FCS
and 250 lg/mL geneticin (G418) at 378C and 5% CO2, as
described previously.33 All experiments were performed in
unsupplemented or serum-free cell culture medium.
Measurement of TGF-b Signaling Activity by
Luciferase Assay
The activity of TGF-b1 signaling was measured in MLECs that
were stably transfected with a luciferase reporter under the
control of a TGF-b responsive truncated plasminogen activator
inhibitor (PAI)-promotor fragment (Serpine1).33 Then, 23 104
MLECs per well were seeded on a 96-well tissue culture plate,
allowed to attach, and starved overnight in serum-free cell
culture medium. After incubation of cells with 100 ng/mL
Dickkopf (DKK)-1 (R&D Systems), 1 ng/mL TGF-b1 (R&D
Systems) and/or 40 ng/mL Norrin for 20 hours, MLEC were
lysed and luciferase activity was measured as described
previously with an Autolumat LB953 (Berthold Technologies,
Oak Ridge, TN, USA).34 Luciferase activity was indicated as
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relative light unit. All measurements were performed in
triplicates.
RNA Isolation, cDNA Synthesis, and Real-Time RT-
PCR Analyses
Total RNA from human retinal microvascular endothelial cells
and homogenized mouse retinae was isolated with peqGOLD
TriFast (Peqlab, Erlangen, Germany) according to the manu-
facturer’s instructions. A NanoDrop spectrophotometer ND-
2000c (Peqlab) was used to measure the RNA concentration
and the OD260/OD280 ratio. Only total RNA with a 260/280
ratio between 1.6 and 2.0 was used for first-strand cDNA
synthesis with the iScript cDNA Synthesis Kit (Bio-Rad
Laboratories). Real-time RT-PCR analyses were performed on
a Bio-Rad iQ5 Real-Time PCR Detection System (Bio-Rad
Laboratories). HotStar Taq DNA polymerase (Qiagen, Hilden,
Germany) was used for PCR according to the manufacturer’s
protocol. PCR was performed in a volume of 15 lL, consisting
of 1.5 lL 10X PCR buffer (Qiagen), 1.5 lL 25 mM MgCl2
(Qiagen), 0.3 lL dNTPs (10 mM each, Qiagen), 0.3 lL HotStart
Taq (5 U/lL), and 1.5 lL of 1X SYBR green I solutions (Sigma-
Aldrich Corp.). The following temperature profile was used: 40
cycles with 10 seconds denaturation at 958C, 40 seconds of
annealing and extension at 608C. RNA that had not been
reverse-transcribed served as negative control for real-time RT-
PCR. All PCR primers (Table) were designed to span exon-
intron boundaries and were purchased from Life Technologies.
For relative quantification, the housekeeping genes GNB2L1
for HRMEC and LaminA for mouse retinae were used. Results
were analyzed using the iQ5 optical system software (version
2.1).
Western Blot Analyses and pSMAD3 ELISA
Murine retinal proteins were isolated in radioimmunoprecip-
itation assay (RIPA) buffer as described previously.17 Protein
concentration was measured by the BCA (Interchim, San
Diego, CA, USA) method and up to 25 lg total proteins were
subjected to 10% SDS-PAGE. Proteins subsequently were
transferred on a polyvinylidine fluoride (PVDF) membrane
(Roche, Basel, Switzerland) by semidry blotting. After blocking
with 5% BSA (b-catenin) or 5% low fat milk (SMAD7) in PBS-T,
membranes were incubated overnight with a rabbit-anti-b-
catenin (1:1000; Cell Signaling Technology, Danvers, MA, USA)
or goat anti-SMAD7 antibody (1:500; Santa Cruz Biotechnology,
Dallas, TX, USA) in PBS-Tween (PBS-T) with 0.5% BSA or 0.5%
low fat milk, respectively. Horseradish peroxidase (HRP)–
conjugated antibodies were used as secondary antibodies (both
from Santa Cruz Biotechnology). Antibody hybridization was
visualized using the Immobilon HRP substrate (Millipore,
Burlington, MA, USA) and documented with the LAS 3000
Imager work station (Fujifilm, Tokyo, Japan). As a loading
control, an HRP-conjugated anti-GAPDH antibody was used
(Cell Signaling Technology). The densitometry of Western blot
analyses was performed with the Aida Image Analyzer v.4.06
software (Raytest, Angleur, Belgium). Relative protein concen-
trations for pSMAD3 were analyzed by ELISA following
manufacturer’s recommendations (Cell Signaling Technology).
In brief, protein concentrations of retinal samples were
measured by the BCA method and 10 lg total protein was
subjected to pSMAD3 ELISA. For read out, the absorbance at
450 nm was measured with an ELISA plate reader (Tecan,
Ma¨nnedorf, Switzerland).
Light Microscopy
Eyes were enucleated and fixed in cacodylate buffer with 2.5%
PFA (Carl Roth) and 2.5% glutaraldehyde (Serva, Heidelberg,
Germany) for 4 hours. After washing overnight in cacodylate
buffer, eyes were postfixed with OsO4, dehydrated, and
embedded in Epon according to standard protocols (Carl
Roth). Semithin sagittal sections (1 lm) of eyes were stained
TABLE. Primers Used for Real-Time RT-PCR Amplification
Gene Accession No. Sequence Position Product Size, bp
Mouse primers
Axin2 NM_015732 50-gagagtgagcggcagagc-30 2216–2233 104
50-cggctgactcgttctcct-30 2319–2302
Fzd4 NM_008055.4 50-actttcacgccgctcatc-30 562–579 72
50-tggcacataaaccgaacaaa-30 633–614
Lrp5 NM_008513 50-tggctgtgcttcacactaca-30 2897–2916
50-ggctgaacagcaagaaggtg-30 2973–2954
Smad7 NM_001042660 50-acccccatcaccttagtcg-30 2172–2190 75
50-gaaaatccattgggtatctgga-30 2246–2225
Tgf-b1 NM_011577 50-tggagcaacatgtggaactc-30 1358–1377 73
50-gtcagcagccggttacca-30 1430–1413
Tgf-b2 NM_009367 50-aggaggtttataaaatcgacatgc-30 1520–1543 67
50-tagaaagtgggcgggatg-30 1586–1569
Tgfbr1 NM_009370 50-gcagctcctcatcgtgttg -3 0 40–58 77
50-agaggtggcagaaacactgtaat-30 116–94
Tgfbr2 NM_009371 50-agaagccgcatgaagtctg-30 634–652 72
50-ggcaaaccgtctccagagta-30 705–686
Tgfbr3 NM_011578 50-ctccccaggggtcttctc-30 2246–2263 74
50-cttggtcagccttagtgacaga-30 2319–2298
Lamin A/C NM_001002011 50-agcaaagtgcgtgaggagtt-30 568–587 62
50-aggtcaccctccttcttggt-30 629–610
Human primers
SERPINE1 NM_000602 50-aaggcacctctgagaacttca-30 135–155 61
50-gaggtggccttctgacacag-30 195–178
GNB2L1 NM_006098 50-gctactaccccgcagttcc-30 170–188 72
50-cagtttccacatgatgatggtc-30 241–220
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with fuchsin-methylene blue and analyzed by light microscopy
on an Axiovision microscope (Carl Zeiss).
Immunohistochemistry and TUNEL Labeling
For immunohistochemistry and TUNEL labeling (Promega,
Madison, WI, USA), eyes were fixed with 4% PFA for 4 hours
and embedded in paraffin according to standard procedures.
For pSMAD3 staining, sections were incubated in 0.1 M sodium
citrate (pH 7.4) at 1008C for 20 minutes, washed with 1X tris-
buffered saline (TBS), at room temperature for 5 minutes and
blocked with 2% BSA, 0.2% cold water fish gelatin (Aurion,
Wageningen, The Netherlands) and 0.1% Triton X-100 in 1X
TBS for 60 minutes. After three washes (10 minutes each) with
1X TBS, sections were incubated with rabbit anti-pSMAD3
antibodies (1:100, Cell Signaling Technology) in 0.2% BSA,
0.02% cold water fish gelatin, and 0.01% Triton X-100 in 1X
TBS overnight at 48C. For detection of collagen type IV,
sections were pretreated with proteinase K (100 lL proteinase
K [Sigma-Aldrich Corp.] in 57 mL Tris-HCl [0.05 mol/L]) for 5
minutes, washed in water, and incubated in 2N HCl for 20
minutes. After washing with phosphate buffer (0.1 M) 3 times
for 5 minutes, sections were blocked with 2% BSA for 60
minutes before incubation with rabbit anti-collagen type IV
antibodies (1:100; Chemicon International, Temecula, CA,
USA) in 0.2% BSA overnight at 48C. Before adding biotinylated
anti-rabbit antibodies (1:500; Vector Laboratories, Burlingame,
CA, USA) for 60 minutes, slices were washed three times (10
minutes each) with 1X TBS for pSMAD3 and with 0.1 M
phosphate buffer for collagen type IV staining. Following an
additional three washes (10 minutes each) with 1X TBS or 0.1
M phosphate buffer, samples were incubated with Alexa488
coupled streptavidin (1:1000; Molecular Probes, Eugene, OR,
USA) for 60 minutes. After final incubation, all specimens were
washed again three times, mounted in fluorescent mounting
medium containing 1:50 40,6-diamidino-2-phenylendole (DAPI;
Vector Laboratories), and analyzed on an Axiovision fluores-
cent microscope (Carl Zeiss, Jena, Germany).
Apoptotic retinal cells were detected by TUNEL assay using
the Deadend Fluorometric TUNEL system (Promega). TUNEL-
labeling of paraffin sections was performed according to the
manufacturer’s instructions. For quantification, the total
number of TUNEL-positive cells were quantified in the entire
retina of sagittal sections and calculated as the number of
TUNEL-positive cells per 10,000 lm2 retina.
Statistics
All values are expressed as mean 6 SEM. For statistical
analyses, a 1-way ANOVA was performed to compare the mean
variables, followed by a least significant difference (LSD) post
hoc test for data that meet the criteria of the assumption of
homogeneity of variances and a Games Howell post hoc test
for data that did not meet the criteria of homogeneity of
variances. P values less than 0.05 were considered statistically
significant.
RESULTS
Norrin Inhibits Anti-Angiogenic Effects of TGF-b
on Retinal Vasculature and Choriocapillaris
In a recent study, we showed that transgenic bB1-TGF-b1
mice35 with ocular overexpression of active TGF-b1 complete-
ly lack intraretinal capillaries and the layer of the choriocap-
illaris that is required for oxygen supply and nutrition of
photoreceptors.24 We now crossed transgenic bB1-TGF-b1
mice with bB1-Norrin animals that overexpress Norrin in the
eye8,35 to generate double transgenic bB1-TGF-b1/bB1-Norrin
mice. After perfusion with FITC-coupled dextran, well-struc-
tured superficial and deep vascular plexuses were observed in
retinae of wild type and transgenic bB1-Norrin mice at P16
(Figs. 1A, 1B). In addition, in the inner plexiform layer, a few
vessels were seen that began to form the intermediate vascular
plexus (Figs. 1A, 1B). In contrast, as expected, in transgenic
bB1-TGF-b1 mice no intraretinal capillaries were observed (Fig.
1C). However, in retinae of double transgenic bB1-TGF-b1/bB1-
Norrin mice, well established superficial as well as deep
vascular plexuses were detected (Fig. 1D). Moreover, in
meridional sections of retinae from bB1-Norrin mice and wild
type littermates, vessels of the choriocapillaris were observed
adjacent to the RPE (Figs. 1E, 1F), suggesting an intact and
dense choroidal capillary network, which was not detectable
in transgenic bB1-TGF-b1 mice (Fig. 1G). The loss of the
choriocapillaris was rescued in double transgenic mice, in
which vessels that lie close to the RPE were readily detected
(Fig. 1H). To confirm our observations in an independent assay,
immunostaining for collagen type IV was performed to
visualize the basal lamina of microvascular endothelial cells
in the retina.22 In the central inner retina of wild type mice, a
dense capillary network was observed below the inner limiting
membrane, which also was labeled (Fig. 1I). As expected, at P8
the vessels of the superficial vascular plexus spread from the
retinal center to its periphery (Fig. 1I). In contrast, retinae of
bB1-TGF-b1 transgenic mice completely lacked the retinal
vasculature (Fig. 1K). Only a thickened inner limiting
membrane was seen covering the retinal surface (Fig. 1K).
The absence of retinal vessels in bB1-TGF-b1 mice was rescued
in double transgenic littermates in which numerous vessels
were detected in all regions of the inner retina (Fig. 1L).
Overall, our observations strongly indicated that Norrin
inhibits the anti-angiogenic effects of TGF-b on retinal
capillaries and choriocapillaris.
Norrin Prevents Neuronal Apoptosis in the Retina
of bB1-TGF-b1 Mice
We previously reported that the combined lack of retinal
capillaries and choriocapillaris in bB1-TGF-b1 mice is associat-
ed with pronounced apoptosis of retinal neurons.24 Therefore,
we wanted to know if retinal apoptosis is attenuated in double
transgenic bB1-TGF-b1/bB1-Norrin animals. By light microsco-
py, we observed in the retina of transgenic bB1-TGF-b1 mice a
substantial number of pyknotic nuclei compared to bB1-Norrin
or wild type littermates (Figs. 2A–C). In contrast to bB1-TGF-b1
mice, in double transgenic bB1-TGF-b1/bB1-Norrin animals the
number of pyknotic nuclei was obviously lower (Fig. 2D). To
further confirm our observation by an independent assay,
apoptotic retinal cells were stained by TUNEL. On retinal
meridional sections from bB1-Norrin mice and wild type
littermates only very few apoptotic cells in the inner retina
were observed (Figs. 2E, 2F). In contrast, in transgenic bB1-
TGF-b1 animals, a substantial number of TUNEL-positive cells
were detected in the inner (INL) and outer (ONL) nuclear
layers of the retina (Fig. 2G). Quite remarkably, the increase in
TUNEL-positive cells in the retina was substantially attenuated
in double transgenic bB1-TGF-b1/bB1-Norrin mice (Fig. 2H), an
observation that we confirmed by quantification. In bB1-Norrin
and wild type littermates, only 1.6 6 0.1 and 1.5 6 0.2 TUNEL-
positive cells per 10,000 lm2 retina were detected, respec-
tively (Fig. 2I). In contrast, in transgenic bB1-TGF-b1 mice the
number of apoptotic retinal cells was increased significantly by
2.5-fold compared to wild type littermates (3.9 6 1.6; P <
0.001; Fig. 2I). However, in double transgenic mice, the
number of TUNEL-positive cells was substantially reduced by
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more than 35% compared to bB1-TGF-b1 mice (2.4 6 0.4; P¼
0.01; Fig. 2I), strongly suggesting that the Norrin-induced
rescue of retinal and choroidal capillaries inhibits, at least
partially, the neuronal apoptosis in retinae of bB1-TGF-b1 mice.
As reported previously, the vitreous cavity fails to develop in
transgenic bB1-TGF-b1 mice with the result that the posterior
side of the lens comes in contact with the retina (Fig. 2C).35 In
contrast, in transgenic bB1-Norrin mice, a well-established
vitreous body and a normal structured retina are observed at
P5 (Fig. 2B).8 Moreover, in double transgenic bB1-TGF-b1/bB1-
Norrin animals a small but distinct vitreous cavity was formed
(Fig. 2D) indicating that Norrin attenuates TGF-b–induced
effects on ocular morphogenesis in vivo.
Norrin Restores TGF-b–Induced Suppression of b-
Catenin
Since our data indicated that Norrin attenuates TGF-b–induced
effects, we wondered which underlying mechanism mediates
the effects. Following this, we first analyzed b-catenin protein
levels in retinae of double transgenic animals. In wild type
mice a specific band for b-catenin was detected at P8, an
observation that was more pronounced in transgenic bB1-
Norrin mice (Fig. 3A). However, in bB1-TGF-b1 mice, the levels
for b-catenin in the retina were dramatically reduced compared
to wild type littermates. This effect was restored in double
transgenic bB1-TGF-b1/bB1-Norrin mice (Fig. 3A). Quantifica-
tion of the protein levels from transgenic bB1-TGF-b1 mice by
densitometry detected a significant reduction of b-catenin by
approximately 60% compared to wild type controls (0.41 6
0.16; P < 0.001; Fig. 3B). In retinae of double transgenic bB1-
TGF-b1/bB1-Norrin mice, the diminished protein levels for b-
catenin in bB1-TGF-b1 mice were restored to that of wild type
littermates (0.94 6 0.14), a difference that was statistically
significant (bB1-TGF-b1 versus bB1-TGF-b1/bB1-Norrin P ¼
0.02; Fig. 3B). To further confirm that Norrin not only increases
b-catenin protein levels but also enhances Wnt/b-catenin
signaling, mRNA levels for Axin2 were analyzed. Following
activation of Wnt/b-catenin signaling, the mRNA expression of
Axin2, an inhibitor of Wnt/b-catenin signaling,36,37 is induced,
which is why Axin2 is a common marker for detecting the
activity of Wnt/b-catenin signaling. In retinae of bB1-Norrin
mice, only a moderate increase in Axin2 mRNA level was
detected compared to wild type controls (Fig. 3C). In contrast,
in transgenic bB1-TGF-b1 mice a marked reduction of Axin2
mRNA expression of more than 30% was observed compared
to wild type controls (0.68 6 0.12, P ¼ 0.049; Fig. 3C). This
effect was completely rescued in double transgenic mice (1.12
6 0.13, P ¼ 0.016; Fig. 3C). In summary, our data strongly
suggested that TGF-b mediates a substantial decrease in the
amounts of retinal b-catenin and canonical Wnt/b-catenin
signaling, an effect that is completely antagonized by Norrin.
Norrin Decreases the Phosphorylation of SMAD3
in Inner Retina
Since we found that Norrin restores the TGF-b–mediated
reduction of b-catenin levels, we wondered whether Norrin
might influence the expression of components of the TGF-b or
Wnt/b-catenin pathway. To this end, we first analyzed if Norrin
FIGURE 1. Norrin inhibits anti-angiogenic effects of TGF-b1 on retinal vasculature and on the choriocapillaris. (A–D) Representative meridional
sections through retinae from transgenic bB1-Norrin (B), bB1-TGF-b1 (C), bB1-TGF-b1/bB1-Norrin mice (D), and wild type littermates (A) after
perfusion with FITC-labeled dextran at P16. Blue, DAPI staining. Scale bars: (A–D) 100 lm. (E–H) Representative sagittal sections through the
chorioretinal interface from transgenic bB1-Norrin (F), bB1-TGF-b1 (G), bB1-TGF-b1/bB1-Norrin animals (H), and wild type littermates (E) after
perfusion with FITC-labeled dextran at P16. SC, sclera. Blue, DAPI staining. Scale bars: (E–H) 20 lm. (I–L) Representative collagen type IV staining
(red) on meridional sections through the retina and higher magnifications from the peripheral (top and middle) and central (lower) retina from
transgenic bB1-TGF-b1 (K), bB1-TGF-b1/bB1-Norrin animals (L), and wild type littermates (I) at P8. Blue, DAPI staining. Scale bars: (I–L) 200 lm.
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reduces the expression of TGF-b1 and -b2 or of TGF-b–receptor
(TGFBR)-1, -2 and -3 mRNA or enhances the expression of
FZD4 and LRP5 mRNA in the retinae of double transgenic bB1-
TGF-b1/bB1-Norrin mice. In retinal mRNA from bB1-Norrin
FIGURE 3. Norrin restores TGF-b–induced suppression of b-catenin
signaling in retina. Representative Western blot analysis (A) and
densitometry (B) for b-catenin of retinal proteins from bB1-Norrin, bB1-
TGF-b1, bB1-Norrin/bB1-TGF-b1 mice, and wild type littermates at P8
(*P < 0.05; ***P < 0.001; n ‡ 11 mice per genotype; mean 6 SEM). (C)
Quantitative real-time RT-PCR for Axin2 in retinal mRNA from bB1-
Norrin, bB1-TGF-b1, bB1-Norrin/bB1-TGF-b1 mice, and wild type
controls at P8 (*P < 0.05; n ‡ 6 mice per genotype; mean 6 SEM).
FIGURE 2. Norrin inhibits TGF-b–mediated effects on the vitreoretinal
interface and thereby TGF-b–induced apoptosis. (A–D) Representative
meridional semithin sections through the retina from transgenic bB1-
Norrin (B), bB1-TGF-b1 (C), bB1-TGF-b1/bB1-Norrin animals (D), and
wild type littermates (A) at P5. In double transgenic mice, a small
vitreous cavity (VC) formed and the number of pyknotic nuclei
(arrows) was lower (D) in contrast to transgenic bB1-TGF-b1 animals
(C). Scale bars: (A–D) 40 lm. (E–H) Representative TUNEL staining
(green, arrows) on sagittal sections of retinae from transgenic bB1-
Norrin (F), bB1-TGF-b1 (G), bB1-TGF-b1/bB1-Norrin mice (H), and
wild type littermates (E) at P5. Blue, DAPI staining. Scale bars: (E–H)
50 lm. (I) For quantification, the number of TUNEL-positive cells was
calculated and plotted as apoptotic cells per 10,000 lm2 retina (*P <
0.05; **P < 0.01; n ‡ 7 mice per genotype; mean 6 SEM).
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mice at P8, no significant changes in the expression of any of
those molecules were detected compared to wild type
littermates (Fig. 4). The same was the case for bB1-TGF-b1
and double transgenic bB1-TGF-b1/bB1-Norrin mice, with the
notable exception of Tgfbr3, which was substantially de-
creased in its expression in bB1-TGF-b1 and double transgenic
bB1-TGF-b1/bB1-Norrin mice compared to wild type controls
(Fig. 4). No differences in the retinal expression of any of the
molecules was observed when comparing bB1-TGF-b1 mice
and double transgenic bB1-TGF-b1/bB1-Norrin animals (Fig. 4).
Canonical TGF-b signaling is mediated via the phosphory-
lation of SMAD2 and -3 by TGF-b receptors, which in turn
translocate into the nucleus to induce the expression of
specific target genes.26 Since we could not identify a changed
expression of Tgf-b1 and -b2 and their receptors in retinae of
double transgenic mice, we wondered if Norrin diminishes
canonical TGF-b signaling. To this end, immunohistochemical
staining for phosphorylated SMAD3 (pSMAD3), a key mediator
molecule of the canonical TGF-b pathway, was performed. In
retinae of wild type controls, only a weak staining for pSMAD3
was observed (Fig. 5A). As expected, in retinae of transgenic
bB1-TGF-b1 mice (Fig. 5B), an intense signal for pSMAD3 was
detected in nuclei of the RGC layer and all parts of the INL (Fig.
5B). In contrast, only a weak immunoreactivity for pSMAD3
was seen in the ONL of retinae from mice with an
overexpression of TGF-b1 (Fig. 5A). However, in bB1-TGF-b1/
bB1-Norrin mice no specific staining for pSMAD3 was
observed neither in the RGC layer nor in the INL (Fig. 5C),
strongly suggesting that Norrin inhibits SMAD3 phosphoryla-
tion in retinal neurons and/or neuroglia of the inner retina.
To further confirm our histological observations, an ELISA
for phosphorylated SMAD3 was performed. In retinal proteins
from bB1-Norrin mice at P8 no change in pSMAD3 levels were
observed compared to wild type controls (Fig. 5D). In contrast,
in retinae from transgenic bB1-TGF-b1 mice an 80% increase in
pSMAD3 was detected (1.83 6 0.32; Fig. 5D). The enhanced
phosphorylation of SMAD3 in bB1-TGF-b1 mice was complete-
ly rescued in animals with an additional overexpression of
Norrin (0.84 6 0.17; P¼ 0.029; Fig. 5D). In summary, our data
indicated that the Norrin-induced inhibition of retinal TGF-b
signaling correlates with reduced activity of intracellular
SMAD3 and likely involves the canonical signaling pathways.
FIGURE 4. Norrin has no effect on the mRNA expression of TGF-b1, TGF-b2, TGFBR1, TGFBR2, TGFBR3, and FZD4 or LRP5 mRNA. Quantitative
real-time RT-PCR in retinal mRNA from bB1-Norrin, bB1-TGF-b1, bB1-Norrin/bB1-TGF-b1 mice, and wild type controls at P8 (*P < 0.05; n ‡ 5 mice
per genotype; mean 6 SEM).
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Norrin Inhibits TGF-b Signaling via the Induction
of SMAD7
Since SMAD7 has the distinct potential to inhibit TGF-b
signaling via several mechanisms,38 we analyzed whether
Norrin modulates TGF-b signaling via SMAD7. In retinal mRNA
from 8-day-old bB1-TGF-b1 mice, a significant reduction of
Smad7 levels was detected compared to wild type littermates
(0.47 6 0.06; P ¼ 0.02; Fig. 6A). In contrast, in double
transgenic bB1-TGF-b1/bB1-Norrin mice, the decrease of
retinal SMAD7 mRNA observed in bB1-TGF-b1 animals was
completely normalized compared to wild type controls (1.04
6 0.11; P ¼ 0.002 bB1-TGF-b1 vs. bB1-Norrin/bB1-TGF-b1;
Fig. 6A). To analyze whether the normalization of SMAD7
FIGURE 5. Norrin decreases the phosphorylation of SMAD3 in retina. (A–C) Representative immunohistochemical staining for phosphorylated
SMAD3 (green) on retinal sagittal sections from bB1-TGF-b1 (B), double transgenic bB1-Norrin/bB1-TGF-b1 mice (C), and wild type controls (A) at
P12. Blue, DAPI staining. Scale bars: (A–C) 20 lm. (D) ELISA for pSMAD3 on retinal protein from bB1-Norrin, bB1-TGF-b1, bB1-Norrin/bB1-TGF-b1
animals and wild type controls at P8 (*P < 0.05; n ‡ 6 mice per genotype; mean 6 SEM).
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mRNA in double transgenic mice is followed by an increase in
its translation Western blot analyses were performed. In wild
type controls, specific bands for SMAD7 were detected in
retinal proteins, which were similarly intensive to that from
bB1-Norrin mice (Figs. 6B, 6C). In line with our mRNA data, a
significant decrease of SMAD7 levels by more than 40% was
observed in retinae from bB1-TGF-b1 transgenic mice (0.59 6
0.10; P ¼ 0.015), an effect that was completely blocked in
double transgenic mice compared to wild type controls (1.03
6 0.10; P ¼ 0.048 bB1-TGF- b1 vs. bB1-Norrin/bB1-TGF- b1;
Figs. 6B, 6C). Overall, there is evidence that Norrin antagonizes
the TGF-b pathway via the induction of SMAD7, which in turn
reduces intracellular SMAD3 signaling.
Norrin Inhibits TGF-b Signaling In Vitro
To test if Norrin interferes with the expression of typical target
proteins of TGF-b signaling, the expression of PAI-1 mRNA, a
known SMAD-mediated TGF-b1 responsive protein, was
analyzed in HRMEC by real-time RT-PCR after incubation with
TGF-b1 and/or Norrin. Incubation of HRMEC with Norrin for
16 hours did not change PAI-1 mRNA expression, whereas the
treatment of cells with TGF-b1 induced an up to 3.6-fold
increase in PAI-1 mRNA (3.6 6 0.4; P < 0.001; Fig. 7A). The
TGF-b–mediated effect on PAI-1 mRNA expression was
significantly blocked by approximately 50% when HRMEC
were additionally incubated with Norrin (1.9 6 0.3; P¼ 0.002;
Fig. 7A). To confirm our results by an independent assay, MLEC
that express luciferase under the control of a truncated TGF-b–
sensitive PAI-1 promoter33 were incubated with TGF-b1 and/or
Norrin. After treatment for 20 hours, no difference in luciferase
activity was seen between Norrin-exposed MLEC and untreated
control cells (Fig. 7B). In contrast, in TGF-b1–incubated cells, a
significant increase in luciferase activity (7.0 6 0.3; P < 0.001)
was observed compared to untreated cells (Fig. 7B). The TGF-
b1–mediated effect was significantly reduced by more than
20% when MLEC were additionally incubated with Norrin (5.5
6 0.3; P < 0.001; Fig. 7B).
To analyze whether the inhibitory effect of Norrin on TGF-b
signaling involves the activation of the Wnt/b-catenin signaling
pathway, MLEC were incubated with TGF-b1, Norrin, and/or
FIGURE 6. Norrin inhibits TGF-b signaling via an induction of SMAD7.
(A) Quantitative real-time RT-PCR for Smad7 on retinal RNA from bB1-
Norrin, bB1-TGF-b1, bB1-Norrin/bB1-TGF-b1 animals, and wild type
controls at P8 (*P < 0.05; **P < 0.01; n ‡ 7 mice per genotype; mean
6 SEM). Western blot analysis (B) and densitometry (C) for SMAD7 on
retinal proteins from bB1-Norrin, bB1-TGF-b1, bB1-Norrin/bB1-TGF-b1
mice and wild type controls at P8 (*P < 0.05; n ‡ 11 mice per
genotype; mean 6 SEM).
FIGURE 7. Norrin inhibits TGF-b signaling in vitro. (A) Real-time RT-
PCR for PAI-1 in RNA from HRMEC after treatment with 1 ng/mL TGF-
b1 and/or 40 ng/mL Norrin for 16 hours (n ¼ 4 independent
experiments; mean 6 SEM; **P < 0.01; ***P < 0.001). (B) MLEC were
incubated with 1 ng/mL TGF-b1, 40 ng/mL Norrin and/or 100 ng/mL
DKK-1. After incubation for 20 hours luciferase activity was measured
and plotted as relative light units (**P < 0.01; ***P < 0.001; n¼ 28 per
group of three independent experiments; mean 6 SEM).
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DKK-1, an inhibitor of the Wnt/b-catenin signaling pathway.
After incubation of the cells with DKK-1, no change in
luciferase activity was measured (Fig. 7B). However, after an
additional treatment of the cells with DKK-1, the Norrin-
mediated reduction in TGF-b1–induced luciferase activity was
completely abolished (7.0 6 0.4; P < 0.001; Fig. 7B), strongly
suggesting that Norrin inhibits TGF-b activity via the activation
of the Wnt/b-catenin signaling pathway.
DISCUSSION
We concluded that TGF-b signaling attenuates canonical Wnt/
b-catenin signaling in the retina by reducing the amounts of b-
catenin. This effect is antagonized by Norrin, which increases
the amounts of b-catenin, induces the expression of Smad7, an
inhibitor of canonical TGF-b signaling, and rescues the effects
of TGF-b signaling on the phenotype of the retinal and
choroidal vasculature. Our conclusions rest upon: (1) the
observation that Norrin antagonizes the TGF-b–induced lack of
retinal and choroidal vasculature, and consequently neuronal
apoptosis, (2) the finding that Norrin normalizes TGF-b–
mediated suppression of retinal b-catenin protein levels, (3)
the observation that Norrin inhibits TGF-b–mediated pSMAD3
signaling, (4) the capability of Norrin to induce SMAD7
expression in the presence of high retinal amounts of TGF-b,
(5) the potential of Norrin to reduce TGF-b–mediated
induction of target genes, and finally (6) the finding that
DKK-1 blocks Norrin-mediated effects.
Crosstalk between TGF-b and Wnt/b-catenin signaling is an
extensively studied and common theme during early embry-
onic development and morphogenesis, as well as for tumor
progression in the adult organism.39 During early development
the mutual regulation of TGF-b and Wnt/b-catenin signaling is
required for tissue patterning, a scenario that involves
opposing effects on the developing mesenchyme. While
BMP2 and 4, both members of the TGF-b family, induce the
expression of Wnt-8 in frog mesenchymal cells, BMP2
downregulates Wnt-7 and b-catenin in mesenchymal cells from
chicken.40,41 In contrast, synergistic signaling of the TGF-b and
Wnt/b-catenin pathway has been reported for neuronal
development, gastric cancer, or mesenchymal stem cell self-
renewal.42–44 Quite intriguingly, the crosstalk between TGF-b
and b-catenin signaling is mediated by several transcription
factors of both pathways, SMADs and components of the b-
catenin destruction complex,39 molecules that also similarly
are involved in the crosstalk between TGF-b and Norrin
observed in our study. However, there is substantial evidence
that both signaling pathways exert essentially opposite effects
during fetal growth of retinal and choroidal capillaries, as well
as for their maintenance in the adult mammalian eye. For
development of retinal vasculature in mice, capillaries grow
from the optic nerve head along the inner retina toward its
periphery to form the primary inner retinal vascular plexus
between P0 and P8.45 The primary vascular plexus than
differentiates to a mature vasculature, which requires TGF-b
signaling for pericyte recruitment, maintenance of the blood-
retinal barrier, and microvascular vascular homeostasis.22,46
After the superficial plexus has been established, vessels grow
into the retina to the outer and inner edges of the ONL where
they form the deep and intermediate vascular plexuses.45 For
development of the intraretinal vasculature and for its repair
after injury, Norrin-induced canonical Wnt/b-catenin signaling
is essential,6–8 while TGF-b has pronounced antiangiogenic
effects on retinal and choroidal vessels.23,24 Consequently,
deficiency in TGF-b signaling causes retinal neovasculariza-
tion.22
Development of retinal vasculature involves various inter-
actions between neurons, glia cells, and microvascular
endothelial cells, and is well characterized for the formation
of hypoxia inducible factor (HIF)–1a mediated retinal angio-
genesis.47,48 During development of the retinal vasculature,
hypoxia increases HIF-1a expression in retinal neurons, which
in turn leads to an induction of several angiogenic factors and
subsequently to vessel formation toward the hypoxic reti-
na.47–49 Intriguingly, in a previous study we observed a
substantial decrease of HIF-1a in the inner retina of bB1-TGF-
b1 mice,24 which correlates well with our observation of an
enhanced pSMAD3 signaling in cells of the inner retina. Since
Norrin blocks pSMAD3 phosphorylation in inner retina of
double transgenic mice, it is most likely that Norrin mediates
its inhibitory effects on TGF-b signaling via acting on neurons/
neuroglia in the inner retina. This explanation is supported by
reports of neuronal FZD4 expression in the retinal ganglion
cell layer as well as the INL and ONL.17,50
The critical molecule for canonical Wnt/b-catenin signaling
is cytosolic b-catenin, whose levels are controlled by the b-
catenin destruction complex. In the absence of activating
ligands such as Wnt molecules or Norrin, the complex reduces
the levels of cytosolic b-catenin by promoting its polyubiquiti-
nation and degradation, and thereby keeping the canonical
Wnt/b-catenin signaling inactive. In contrast, Wnt ligands
induce stabilization of b-catenin, and favor its cytosolic
accumulation and translocation into the nucleus to finally
activate canonical Wnt/b-catenin. The marked reduction in the
amounts of b-catenin and Axin2 that we observed in animals
with transgenic TGF-b1 expression is consistent with retinal
inactivity of canonical Wnt/b-catenin signaling. A comparable
TGF-b2-induced and b-catenin-dependent inhibition of canon-
ical Wnt/b-catenin was recently reported for cells of the
trabecular meshwork in the anterior eye.51 In addition, a quite
comparable TGF-b–induced reduction of cellular b-catenin
levels was observed in mesenchymal stem cells or in cultured
human Mu¨ller glia with stem cell characteristics.52,53 Central
molecules for the TGF-b–mediated suppression of Wnt/b-
catenin signaling are SMAD7 and SMAD4. Beside other
molecules, SMAD7 can interact with axin, the scaffold protein
of the b-catenin destruction complex, and thereby induce its
dissociation, which in turn leads to a b-catenin accumulation.54
Since mice with an overexpression of TGF-b have a substantial
decrease in SMAD7 expression, this effect could lead to an
increased activity of the b-catenin destruction complex and
subsequently to reduced b-catenin levels. Vice versa, SMAD4,
which is required for translocation of phosphorylated SMAD2/
3 into the nucleus, is essential for a TGF-b–induced degradation
of b-catenin in cells from the mammary gland.55 An additional
mechanism to decrease b-catenin levels was observed in
glioblastoma cells, in which activation of TGF-b signaling
induces an enhanced expression of the secreted frizzled-
related protein (sFRP)1, a competitive inhibitor of Wnt/b-
catenin signaling trough binding at the cysteine-rich domain of
frizzled receptors.56 Even though the exact mechanism of how
TGF-b suppresses b-catenin signaling in the eye remains
unclear, it is reasonable to assume that the well characterized
function of Norrin as an atypical Wnt ligand and its capability
to activate the canonical Wnt/b-catenin signaling pathway4
causes or contributes to the normalization of b-catenin in mice
with combined Norrin/TGF-b1 overexpression.
Another mechanism to induce cross-inhibition of both
pathways during crosstalk of TGF-b and Wnt signaling is TGF-
b/Wnt–controlled transcription, which may result in the
antagonistic expression of specific target genes. Such a
mechanism might significantly contribute to the effects of
Norrin on TGF-b signaling observed in our study, as Norrin
overexpression caused an increase in the retinal amounts of
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SMAD7 and its mRNA in transgenic mice, which were
substantially reduced when only TGF-b1 was overexpressed.
Transcriptional regulation of SMAD7 expression is versatile and
involves various transcription factors, including pSMAD2/3.57
While pSMAD2/3 are mediators of TGF-b signaling and
enhance the expression of SMAD758 it is tempting to speculate
that Norrin can induce SMAD7 expression via an activation of
Wnt/b-catenin signaling. SMAD7 belongs to the group of
inhibitory SMADs that can block downstream signaling of TGF-
b via various mechanisms. Most prominent are inhibitory
interactions of SMAD7 with TGF-b type I receptors and
activated SMAD2 or 3, leading to their degradation via
ubiquitylation.27 In addition, a lesser-known mechanism was
reported in cortical neurons following inhibition of GSK3b
through LiCl treatment that leads to an increase in pCREB/
p300 signaling, which in turn inhibits pSMAD3 signaling.59
Accordingly, a SMAD7-induced lack of SMAD2/3 activation is a
likely explanation for the decrease in the amounts of
phosphorylated SMAD3 that we observed in eyes with
combined Norrin/TGF-b1 overexpression. Quite intriguingly,
in epithelial cell lines SMAD7 is capable to stabilize b-catenin
by initiating molecular interactions that prevent its phosphor-
ylation and degradation.54 It is tempting to speculate that a
similar mechanism contributes to the increase in the Norrin-
induced amounts of b-catenin despite the presence of active
TGF-b1.
TGF-b and Wnt signaling pathways also are known to
reciprocally regulate their ligand production, an effect that is
used, for example, to establish extracellular gradients of
morphogens during embryonic development. Since we could
neither observe substantial effects of Norrin on the expression
of TGF-b1 and 2, or on their critical receptors TGFbRI and
TGFbRII, nor an effect of TGF-b on the Wnt receptors LRP5 or
FZD4, we regard such a scenario as less relevant during
vascular development and maintenance in the mammalian
retina. We did observe though a Norrin-mediated inhibition of
the expression of PAI-1, which is a very characteristic target
gene of TGF-b signaling. Our observation that DKK-1, an
inhibitor of the frizzled-4 co-receptor LRP5/6,60 blocked the
effect argues for the involvement of canonical Wnt/b-catenin
signaling.
Overall, an extensive cross-inhibition of canonical TGF-b
and Norrin-induced Wnt/b-catenin signaling appears to be an
important element of the signaling cascades that are required
during development of retinal and choroidal capillaries, their
maintenance in the adult eye, and their repair after injury.
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